serw-MX  [xml]  
 
    
 DeCS Categories

C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.163 Brain Diseases, Metabolic .
C10.228.140.163.100 Brain Diseases, Metabolic, Inborn .
C10.228.140.163.100.875 Tyrosinemias .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.565 Metabolism, Inborn Errors .
C16.320.565.100 Amino Acid Metabolism, Inborn Errors .
C16.320.565.100.880 Tyrosinemias .
C16.320.565.189 Brain Diseases, Metabolic, Inborn .
C16.320.565.189.875 Tyrosinemias .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.132 Brain Diseases, Metabolic .
C18.452.132.100 Brain Diseases, Metabolic, Inborn .
C18.452.132.100.875 Tyrosinemias .
C18.452.648 Metabolism, Inborn Errors .
C18.452.648.100 Amino Acid Metabolism, Inborn Errors .
C18.452.648.100.880 Tyrosinemias .
C18.452.648.189 Brain Diseases, Metabolic, Inborn .
C18.452.648.189.875 Tyrosinemias .
D01 Inorganic Chemicals .
D01.268 Elements .
D01.268.185 Chalcogens .
D01.268.185.550 Oxygen .
D01.362 Gases .
D01.362.670 Oxygen .
D02 Organic Chemicals .
D02.309 Dioxins and Dioxin-like Compounds .
D02.309.500 Dioxins .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.231 Dioxins .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.473 Indoles .
D03.633.100.473.725 Oxyphenisatin Acetate .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.682 Oxidoreductases .
D08.811.682.690 Oxygenases .
D08.811.682.690.416 Dioxygenases .
D08.811.682.690.416.330 4-Hydroxyphenylpyruvate Dioxygenase .
SP4 Environmental Health .
SP4.011 Science .
SP4.011.097 Chemistry .
SP4.011.097.039 Chemical Compounds .
SP4.011.097.039.759 Dioxins .
SP4.011.097.063 Elements .
SP4.011.097.063.949 Oxygen .
 
 Terms
 Synonyms & Historicals		Documents
LILACS e MDL		 
Oxyphenisatin Acetate .
Acetfenolisatin .
Diasatine .
Isocrin .
Oxyphenisatine .
Acetate, Oxyphenisatin .
Dioxyphenylisatin .
Oxyphenisatin .
Phenolisatin .
A laxative that undergoes enterohepatic circulation. It may cause jaundice. .
1.00
161
 
Oxygen .
Oxygen-16 .
Oxygen 16 .
Dioxygen .
An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. .
0.50
637145639
 
4-Hydroxyphenylpyruvate Dioxygenase .
Dioxygenase, 4-Hydroxyphenylpyruvate .
Hydroxylase, P-Hydroxyphenylpyruvate .
Hydroxylase, para-Hydroxyphenylpyruvate .
Oxidase, P-Hydroxyphenylpyruvate .
Oxidase, para-Hydroxyphenylpyruvate .
P Hydroxyphenylpyruvate Hydroxylase .
P Hydroxyphenylpyruvate Oxidase .
para Hydroxyphenylpyruvate Hydroxylase .
para Hydroxyphenylpyruvate Oxidase .
P-Hydroxyphenylpyruvate Hydroxylase .
P-Hydroxyphenylpyruvate Oxidase .
para-Hydroxyphenylpyruvate Hydroxylase .
para-Hydroxyphenylpyruvate Oxidase .
An enzyme that catalyzes the conversion of 4-hydroxyphenylpyruvate plus oxygen to homogentisic acid and carbon dioxide. EC 1.13.11.27. .
0.49
1279
 
Dioxins .
A family of compounds that contain the 1,4-dioxin structure. Many specific dioxin derivatives are listed as CARCINOGENS; TERATOGENS; or MUTAGENS. .
0.47
235527
 
Tyrosinemias .
4-Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease .
4-Hydroxyphenylpyruvate Dioxygenase Deficiency .
4-Hydroxyphenylpyruvic Acid Oxidase Deficiency .
Deficiency Disease, 4-Hydroxyphenol Pyruvic Acid Oxidase .
Deficiency Disease, Fumarylacetoacetase .
Deficiency Disease, Tyrosine Transaminase .
Fumarylacetoacetase Deficiency .
Hepatorenal Tyrosinemia .
Hereditary Tyrosinemia, Type I .
Hereditary Tyrosinemia, Type II .
Hereditary Tyrosinemia, Type III .
Hereditary Tyrosinemias .
Hypertyrosinemia .
Hypertyrosinemia, Type I .
Keratosis Palmoplantaris with Corneal Dystrophy .
Oregon Type Tyrosinemia .
Richner-Hanhart Syndrome .
Richner-Hanhart Syndrome, Tyrosinosis, Oculocutaneous Type .
Tat Deficiency .
Tyrosine Aminotransferase Deficiency .
Tyrosine Transaminase Deficiency .
Tyrosinemia .
Tyrosinemia Type 1 .
Tyrosinemia, Type 2 .
Tyrosinemia, Type I .
Tyrosinemia, Type II .
Tyrosinemia, Type III .
Tyrosinemias, Hereditary .
Tyrosinosis, Oculocutaneous Type .
2 Tyrosinemias, Type .
4 Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease .
Deficiencies, 4-Hydroxyphenylpyruvate Dioxygenase .
Deficiencies, Fumarylacetoacetase .
Deficiencies, Tat .
Deficiency Disease, 4 Hydroxyphenol Pyruvic Acid Oxidase .
Deficiency Diseases, Fumarylacetoacetase .
Deficiency, 4-Hydroxyphenylpyruvate Dioxygenase .
Deficiency, Fumarylacetoacetase .
Deficiency, Tat .
Dioxygenase Deficiencies, 4-Hydroxyphenylpyruvate .
Dioxygenase Deficiency, 4-Hydroxyphenylpyruvate .
Disease, Fumarylacetoacetase Deficiency .
Diseases, Fumarylacetoacetase Deficiency .
Fumarylacetoacetase Deficiencies .
Fumarylacetoacetase Deficiency Diseases .
Hepatorenal Tyrosinemias .
Hereditary Tyrosinemia .
Hypertyrosinemias, Type I .
Oculocutaneous Type Tyrosinoses .
Oculocutaneous Type Tyrosinosis .
Richner Hanhart Syndrome .
Richner-Hanhart Syndromes .
Syndrome, Richner-Hanhart .
Syndromes, Richner-Hanhart .
Tat Deficiencies .
Type 2 Tyrosinemia .
Type 2 Tyrosinemias .
Type I Hypertyrosinemia .
Type I Hypertyrosinemias .
Type I Tyrosinemia .
Type I Tyrosinemias .
Type II Tyrosinemia .
Type II Tyrosinemias .
Type III Tyrosinemia .
Type III Tyrosinemias .
Type Tyrosinoses, Oculocutaneous .
Type Tyrosinosis, Oculocutaneous .
Tyrosinemia Type 1s .
Tyrosinemia, Hepatorenal .
Tyrosinemia, Hereditary .
Tyrosinemias, Hepatorenal .
Tyrosinemias, Type 2 .
Tyrosinemias, Type I .
Tyrosinemias, Type II .
Tyrosinemias, Type III .
Tyrosinoses, Oculocutaneous Type .
Fumarylacetoacetase Deficiency Disease .
Tyrosine Transaminase Deficiency Disease .
4 Hydroxyphenylpyruvate Dioxygenase Deficiency Disease .
A group of disorders which have in common elevations of tyrosine in the blood and urine secondary to an enzyme deficiency. Type I tyrosinemia features episodic weakness, self-mutilation, hepatic necrosis, renal tubular injury, and seizures and is caused by a deficiency of the enzyme fumarylacetoacetase. Type II tyrosinemia features INTELLECTUAL DISABILITY, painful corneal ulcers, and keratoses of the palms and plantar surfaces and is caused by a deficiency of the enzyme TYROSINE TRANSAMINASE. Type III tyrosinemia features INTELLECTUAL DISABILITY and is caused by a deficiency of the enzyme 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE. (Menkes, Textbook of Child Neurology, 5th ed, pp42-3) .
0.45
11340